MAPK7 and neoplasm: In cells both siRNA knockdown of ERK5 or XMD8-92 treatment caused an increase in p21CIP1 gene-expression, and XMD8-92 or expression of a dominant-negative ERK5 (AEF: where the activation-loop TEY phosphorylation sites are mutated to AEF) decreased tumour growth32,33.